Article Sidebar
Article Details
Issue
Section
Articles
Copyright for articles published in this journal is retained by the journal.
Main Article Content
Analysis of binding energy activity of TIBO and HIV-RT based on simple consideration for conformational change
Abstract
Tetrahydro-imidazo[4,5,l-jk][1,4]-benzodiazepin-2 (1 H)one (TIBO) is a noncompetitive non nucleotide antiretroviral drug with a specific allosteric binding site of HIV-1 RT. The conformational analysis shows
that the effect of the drug depends on the potential energy which varied due to the beta rotatable dihedral angles (N6 - C15 - C16 = C17) of the TIBO side chain. The change of binding energy between TIBO and HIV-RT due to the variation in beta rotatable dihedral angles was determined. The theoretical simulation for a step size of 30 degrees variation from 0 to 90 degree changes was performed. The derived binding energies range from 0 to 8 kcal/mol. Changes in the beta dihedral angle conformation
critically affects the binding energy. TIBO derivatives that affect the beta angle can change the binding energy between drug and HIV-RT and this can affect drug activity.
that the effect of the drug depends on the potential energy which varied due to the beta rotatable dihedral angles (N6 - C15 - C16 = C17) of the TIBO side chain. The change of binding energy between TIBO and HIV-RT due to the variation in beta rotatable dihedral angles was determined. The theoretical simulation for a step size of 30 degrees variation from 0 to 90 degree changes was performed. The derived binding energies range from 0 to 8 kcal/mol. Changes in the beta dihedral angle conformation
critically affects the binding energy. TIBO derivatives that affect the beta angle can change the binding energy between drug and HIV-RT and this can affect drug activity.
